等待开盘 05-06 09:30:00 美东时间
-0.385
-1.32%
累计净回报超2600%!资管公司潘兴广场上市三日累涨超58%;慧荣科技周涨超52%,Q1营收同比翻倍大超预期>>
05-04 18:33
Avalyn Pharma (AVLN), a biotech focused on developing inhaled therapeutics for the lung disorder pulmonary fibrosis, climbed ~55% on Thursday following an upsized initial public offering that raised t...
05-01 01:27
Avalyn Pharma Inc. announced the pricing of its upsized initial public offering of 16,666,667 shares at $18.00 per share, expecting to raise $300 million. The shares will begin trading on the Nasdaq Global Select Market on April 30, 2026, under the ticker "AVLN," with the offering closing on May 1, 2026. The company, focused on inhaled therapies for rare respiratory diseases, has granted underwriters a 30-day option to purchase an additional 2.5 ...
04-30 01:00